KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
+1.67%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$929M
AUM Growth
+$929M
(-21%)
Cap. Flow
-$406M
Cap. Flow
% of AUM
-43.68%
Top 10 Holdings %
Top 10 Hldgs %
77.4%
Holding
34
New
2
Increased
4
Reduced
22
Closed
2
Top Buys
| 1 |
Vera Therapeutics
VERA
|
$24.2M |
| 2 |
UroGen Pharma
URGN
|
$8.65M |
| 3 |
CytomX Therapeutics
CTMX
|
$4.89M |
| 4 |
Nurix Therapeutics
NRIX
|
$4.26M |
| 5 |
Edgewise Therapeutics
EWTX
|
$3.33M |
Top Sells
| 1 |
AMRN
Amarin Corp
AMRN
|
$192M |
| 2 |
Natera
NTRA
|
$165M |
| 3 |
Immunocore
IMCR
|
$22.6M |
| 4 |
Legend Biotech
LEGN
|
$20.7M |
| 5 |
Celldex Therapeutics
CLDX
|
$8.13M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Celldex Therapeutics
CLDX
$1.47B
| $124M | 13.37% |
6,100,729
-399,271
| -6% | -$8.13M |
|
2
Vaxcyte
PCVX
$4B
| $99.9M | 10.75% |
3,071,588
-128,412
| -4% | -$4.17M |
|
|
3
Vera Therapeutics
VERA
$1.38B
| $80.7M | 8.69% |
3,426,887
+1,026,887
| +43% | +$24.2M |
|
4
Syndax Pharmaceuticals
SNDX
$1.41B
| $79.8M | 8.59% |
8,520,000
| – | – |
|
5
BioCryst Pharmaceuticals
BCRX
$1.74B
| $75.8M | 8.16% |
8,463,742
-464,781
| -5% | -$4.16M |
|
6
CG Oncology
CGON
$2.04B
| $63.9M | 6.88% |
2,457,667
-153,995
| -6% | -$4M |
|
7
Viridian Therapeutics
VRDN
$1.5B
| $61.9M | 6.66% |
4,427,927
-272,073
| -6% | -$3.8M |
|
8
Cogent Biosciences
COGT
$1.69B
| $61M | 6.56% |
8,492,557
-612,443
| -7% | -$4.4M |
|
9
Beam Therapeutics
BEAM
$1.66B
| $41.1M | 4.43% |
2,417,647
-100,523
| -4% | -$1.71M |
|
|
10
Immunocore
IMCR
$1.62B
| $30.6M | 3.3% |
976,267
-719,309
| -42% | -$22.6M |
|
11
Wave Life Sciences
WVE
$1.53B
| $29.6M | 3.19% |
4,560,053
-339,444
| -7% | -$2.21M |
|
12
Travere Therapeutics
TVTX
$1.56B
| $22.8M | 2.46% |
1,540,691
-262,059
| -15% | -$3.88M |
|
13
Tyra Biosciences
TYRA
$675M
| $22.3M | 2.4% |
2,329,998
-76,069
| -3% | -$728K |
|
14
Dynavax Technologies
DVAX
$1.19B
| $21.3M | 2.29% |
2,145,319
-475,478
| -18% | -$4.72M |
|
15
enGene Holdings
ENGN
$236M
| $18.2M | 1.96% |
4,994,090
| – | – |
|
16
Cullinan Oncology
CGEM
$445M
| $15.8M | 1.7% |
2,095,998
-242,631
| -10% | -$1.82M |
|
|
17
Nurix Therapeutics
NRIX
$714M
| $13.4M | 1.44% |
1,173,605
+373,605
| +47% | +$4.26M |
|
18
Relay Therapeutics
RLAY
$619M
| $9.99M | 1.08% |
2,887,014
-176,278
| -6% | -$610K |
|
|
AMRN
19
Amarin Corp
AMRN
$311M
| $9.34M | 1.01% |
576,111
-11,838,517
| -95% | -$192M |
|
|
20
UroGen Pharma
URGN
$900M
| $9M | 0.97% |
656,573
+631,573
| +2,526% | +$8.65M |
|
|
21
CytomX Therapeutics
CTMX
$336M
| $4.89M | 0.53% |
+2,154,413
| New | +$4.89M |
|
22
Geron
GERN
$893M
| $4.87M | 0.52% |
3,456,318
-203,208
| -6% | -$287K |
|
23
Ironwood Pharmaceuticals
IRWD
$214M
| $3.92M | 0.42% |
5,466,825
-356,113
| -6% | -$255K |
|
24
Caribou Biosciences
CRBU
$174M
| $3.87M | 0.42% |
3,067,774
-201,373
| -6% | -$254K |
|
25
Sutro Biopharma
STRO
$72.7M
| $3.63M | 0.39% |
5,088,099
-353,348
| -6% | -$252K |
|